Author

N. Conrad

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Antihypertensive Treatment and Risk of Metabolic Associated Fatty Liver Disease: A Drug-Target Mendelian Randomization.

BACKGROUND Metabolic dysfunction-associated fatty liver disease, conventionally known as nonalcoholic fatty liver disease (NAFLD), affects over a quarter of the global population and lacks approved pharmacological treatments. We investigated whether elevated blood pressure (BP) is a modifiable risk factor for NAFLD and...

Yifan Hu, K. Smith-Byrne, Z. Bidel et al. · HYPERTENSION · 0 citations

Review Aug 2026

Cardiovascular disease in pregnancy: physiology, global burden, risk stratification, and opportunities in care.

Cardiovascular disease remains one of the leading causes of maternal mortality worldwide and a major driver of long-term morbidity. Yet, pregnancy-related cardiovascular complications are often under-recognised and variably managed across global settings. This three-part Series examines the continuum of cardiovascular...

Tiffany L. Brazile, N. Conrad, Lina Bergman et al. · The Lancet · 1 citation